SB 421: AN ACT Relative to Insurance Coverage for Prescription Contraceptives
Historically oral and other hormonal contraceptives prescribed by a provider have been available on a month-by-month basis, even though the prescription has been written by the provider for a 12-month period. The insurance restrictions have been imposed under utilization review that limits quantity to a by-month basis, necessitating that the women return to pharmacy each month for her supply. This is viewed within the provider community as a limiting factor to contraceptive access and a potential contributor to contraceptive failure. Senate Bill 421was developed separate from but as a companion to House Bill 1822-FN (An Act making hormonal contraceptives available directly from pharmacists by means of a standing order). In the Final Report of the Commission studying and developing House Bill 1822-FN, there is statement of the Commission endorsement of LSR 2018-2993, which is now SB 421. Senate Bill 421 states that an insurer shall not impose utilization review requirements or other limitations to control of the prescribed or dispensing of contraceptives to an amount less than a 12-month supply, if that quantity is prescribed. (Prepared by Sara Kellogg-Meade, MS, RN)
NHNA’s Commission on Government Affairs is in favor of the passage of SB 421.
A public hearing on this bill is scheduled for February 20, 2018, at 1:45 pm in SH Room 100.